DK1529041T3 - Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel - Google Patents

Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel

Info

Publication number
DK1529041T3
DK1529041T3 DK03784088T DK03784088T DK1529041T3 DK 1529041 T3 DK1529041 T3 DK 1529041T3 DK 03784088 T DK03784088 T DK 03784088T DK 03784088 T DK03784088 T DK 03784088T DK 1529041 T3 DK1529041 T3 DK 1529041T3
Authority
DK
Denmark
Prior art keywords
amidinophenylaminomethyl
hydroxycarbonylethyl
benzimidazol
pyridyl
amide
Prior art date
Application number
DK03784088T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Busch
Norbert Hauel
Florian Colbatzky
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1529041T3 publication Critical patent/DK1529041T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK03784088T 2002-08-02 2003-07-28 Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel DK1529041T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10235639A DE10235639A1 (de) 2002-08-02 2002-08-02 Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
DK1529041T3 true DK1529041T3 (da) 2007-01-08

Family

ID=30469409

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784088T DK1529041T3 (da) 2002-08-02 2003-07-28 Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel

Country Status (23)

Country Link
US (2) US6900229B2 (zh)
EP (1) EP1529041B1 (zh)
JP (1) JP4230453B2 (zh)
KR (1) KR101110088B1 (zh)
CN (1) CN100391957C (zh)
AR (1) AR040763A1 (zh)
AT (1) ATE342265T1 (zh)
AU (1) AU2003255304B2 (zh)
BR (1) BR0313179A (zh)
CA (1) CA2494024C (zh)
CY (1) CY1105734T1 (zh)
DE (2) DE10235639A1 (zh)
DK (1) DK1529041T3 (zh)
EA (1) EA008249B1 (zh)
ES (1) ES2274300T3 (zh)
HK (1) HK1081553A1 (zh)
IL (1) IL166584A (zh)
MX (1) MXPA04012945A (zh)
PL (1) PL218430B1 (zh)
PT (1) PT1529041E (zh)
TW (1) TWI313682B (zh)
WO (1) WO2004014894A1 (zh)
ZA (1) ZA200409940B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10235639A1 (de) * 2002-08-02 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
DE102005020002A1 (de) * 2005-04-27 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
DE102005025728A1 (de) * 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
CL2007002068A1 (es) * 2006-07-17 2008-01-18 Boehringer Ingelheim Int Uso de dabigatran, etexilato de dabigatran, (n-2-piridil-n-2-etoxicarboniletil)amida del acido 1-metil-2-[4-(n-hidroxiamidino)fenilaminoetil]bencimidazol-5-il-carboxilico, melagatran, ximelagatran, hirudina, hirulog y argatroban para el tratamiento de infarto cerebral, infarto de miocardio, trombosis, embolia pulmonar, entre otras.
CA2657269A1 (en) * 2006-07-17 2008-01-24 Boehringer Ingelheim International Gmbh New indications for direct thrombin inhibitors
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
CN102875529B (zh) * 2011-07-15 2015-04-22 天津药物研究院 达比加群的酯衍生物及其制备方法
EP2550966B1 (de) 2011-07-25 2016-10-19 Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG Dabigatran-Amidoximsäureesters als Prodrugs und ihre Verwendung als Arzneimittel
CN103420994B (zh) * 2012-05-24 2016-04-06 天津药物研究院 作为前药的达比加群酯衍生物及其制备方法和用途
CN102766134B (zh) * 2012-07-19 2014-06-25 北京普禄德医药科技有限公司 达比加群的酯衍生物及其制备方法和用途
WO2014012236A1 (zh) * 2012-07-19 2014-01-23 北京普禄德医药科技有限公司 达比加群的酯衍生物及其制备方法和用途
CN107027308A (zh) * 2014-08-06 2017-08-08 四川海思科制药有限公司 一种达比加群硫酯衍生物及其制备方法和在药学上的用途
CN111440149A (zh) * 2020-03-31 2020-07-24 浙江美诺华药物化学有限公司 一种达比加群酯中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
CA2134192A1 (en) * 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US6414008B1 (en) 1997-04-29 2002-07-02 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
DE10235639A1 (de) * 2002-08-02 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
TW200408636A (en) 2004-06-01
PT1529041E (pt) 2007-01-31
US6900229B2 (en) 2005-05-31
EP1529041B1 (de) 2006-10-11
CY1105734T1 (el) 2010-12-22
EA200500261A1 (ru) 2005-08-25
CA2494024A1 (en) 2004-02-19
PL218430B1 (pl) 2014-12-31
EA008249B1 (ru) 2007-04-27
TWI313682B (en) 2009-08-21
CN1675193A (zh) 2005-09-28
AR040763A1 (es) 2005-04-20
AU2003255304B2 (en) 2009-10-01
ATE342265T1 (de) 2006-11-15
US7189743B2 (en) 2007-03-13
AU2003255304A1 (en) 2004-02-25
KR20050026565A (ko) 2005-03-15
US20050137233A1 (en) 2005-06-23
ZA200409940B (en) 2006-06-28
ES2274300T3 (es) 2007-05-16
US20040059118A1 (en) 2004-03-25
WO2004014894A1 (de) 2004-02-19
JP2005536528A (ja) 2005-12-02
KR101110088B1 (ko) 2012-02-15
PL373088A1 (en) 2005-08-08
IL166584A0 (en) 2006-01-15
DE50305374D1 (de) 2006-11-23
JP4230453B2 (ja) 2009-02-25
CN100391957C (zh) 2008-06-04
EP1529041A1 (de) 2005-05-11
HK1081553A1 (en) 2006-05-19
IL166584A (en) 2011-12-29
CA2494024C (en) 2010-12-21
BR0313179A (pt) 2005-06-14
DE10235639A1 (de) 2004-02-19
MXPA04012945A (es) 2005-05-16

Similar Documents

Publication Publication Date Title
DK1529041T3 (da) Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel
EA200401136A1 (ru) Предназначенная для перорального применения лекарственная форма для этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1h-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его солей
NO20043612L (no) Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler
DK1598333T3 (da) Fremgangsmåde til fremstilling af (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutan og syreadditionssalte heraf samt anvendelse til syntese af ivabradin og syreadditionssalte heraf med farmaceutisk acceptable syrer
NO20033815L (no) Farmasöytiske salter
NO2014005I1 (no) olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav
FI7617U1 (fi) Amorfisen aktiivisen ainesosan stabiloitu farmaseuttinen valmiste
NO20045679D0 (no) Nye fysiologisk aktive substanser
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
NO20040564L (no) Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
NO20043442L (no) Nye substituerte benzimidazol-doseringsformer og fremgangsmater for anvendelse av samme
DE60318133D1 (de) Wasserfreies L-Lysin als Hauptbestandteil enthaltendes Granulat
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
DK1414824T3 (da) Nye antikonvulsive derivatsalte
ATE353878T1 (de) Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
ITRM20020016A1 (it) Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
DK1478366T3 (da) Farmaceutiske kombinationer af meloxicam, codeinphosphat og paracetamol
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
NO20044867L (no) Nye salter
NO20050183L (no) Farmasoytiske salter av reboxetin